ERP
Live / Registered — Registered — Section 8 accepted (as of 09 Sept 2026)
What this means for you
Registered since 25 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88221611
- Registration number
- 6137043
- Mark type
- Stylized text
- Filed
- 07 Dec 2018
- Published for opposition
- 22 Oct 2019
- Registered
- 25 Aug 2020
- Attorney of record
- Charles J. Meyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical purposes for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; plasma for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic and therapeutic preparations for medical or veterinary use, in particular preparations produced using molecular biological, biotechnological and genetic methods; surgical implants grown from stem cells; stem cells for medical purposes; pharmaceutical preparations for stem cell transplantation, therapy and research; pharmaceutical and veterinary preparations for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; sanitary preparations for medical purposes; blood plasma; reagents for medical purposes; medical diagnostic reagent; biological preparations for medical purposes used in the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; chemical preparations for pharmaceutical purposes, namely, chemical preparations for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic preparations for medical purposes; pharmaceutical products for the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders
Owner
- Mononuclear Therapeutics Limited, Shatin NT, HK
- Mononuclear Therapeutics Limited, Shatin NT, HK
- Mononuclear Therapeutics Limited, Shatin NT, HK
Prosecution history
- 09 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 09 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 07 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jul 2026 — TEAS SECTION 8 RECEIVED
- 25 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 23 Jul 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Jul 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Jun 2020 — USE AMENDMENT FILED
- 01 Jul 2020 — SOU EXTENSION 1 GRANTED